Small cell carcinoma of the lung medical therapy

Small Cell Carcinoma of the Lung Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Small Cell Carcinoma of the Lung from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Radiation Therapy
Surgery
Prevention
Future or Investigational Therapies
Case Studies
Case #1
Small cell carcinoma of the lung medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Small cell carcinoma of the lung medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Small cell carcinoma of the lung medical therapy
CDC on Small cell carcinoma of the lung medical therapy
Small cell carcinoma of the lung medical therapy in the news
Blogs on Small cell carcinoma of the lung medical therapy
Directions to Hospitals Treating Small cell carcinoma of the lung
Risk calculators and risk factors for Small cell carcinoma of the lung medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Patients with small cell carcinoma (SCC) of the lung have many treatment options. The selection depends on the stage of the tumor. The options are radiation therapy, chemotherapy, surgery, or a combination of these methods. Before treatment starts, ask your health care team about possible side effects and how treatment may change your normal activities. Because cancer treatments often damage healthy cells and tissues, side effects are common. Side effects may not be the same for each person, and they may change from one treatment session to the next.

Initial Medical Therapy

Limited Stage SCC

Limited stage SCC

Clinical stage T(1-2),N(0)

Limited stage in excess of T(1-2),N(0)

What is the statuses of the pathologic mediastinal staging AND operability of the patient?

Negative pathologic mediastinal staging AND Patient is medically operable

Positive pathologic mediastinal staging OR Patient is medically operable

Lobectomy PLUS Lymph node dissection or sampling

What is the status of involvement of the lymph nodes?

N0

N+

Chemotherapy

Chemotherapt PLUS Mediastinal radiotherapy

References

Template:WikiDoc Sources